SLC22A1 and liver cancer: The results showed that UBE2C, PTTG1, TOP2A and SPP1 were positive, FCN3, SLC22A1, ADH4, CYP2C8, SLC10A1, and FBP1 were negative in liver cancer tissues (Fig. 2G).